SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001387131-20-003786
Filing Date
2020-04-08
Accepted
2020-04-08 17:10:10
Documents
9

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT tnxp-s3_040820.htm S-3 355152
2 SALES AGREEMENT ex1-02.htm EX-1.02 285034
3 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 23878
4 OPINION OF LOWENSTEIN SANDLER, LLP ex5-02.htm EX-5.02 15674
5 CONSENT OF EISNERAMPER LLP ex23-01.htm EX-23.01 4498
6 GRAPHIC tonix_logo.jpg GRAPHIC 29819
7 GRAPHIC ex5-1_img001.jpg GRAPHIC 20591
8 GRAPHIC ex5-2_img001.jpg GRAPHIC 5435
9 GRAPHIC ex5-2_img002.jpg GRAPHIC 11301
  Complete submission text file 0001387131-20-003786.txt   778327
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237610 | Film No.: 20782552
SIC: 2834 Pharmaceutical Preparations